ARTICLE | Clinical News
Istradefylline regulatory update
April 9, 2012 7:00 AM UTC
Kyowa submitted an NDA to Japan's Ministry of Health, Labor and Welfare for istradefylline (KW-6002) to treat Parkinson's disease. Istradenfylline is an adenosine A2A receptor antagonist. ...